Skip to main content

Table 4 Anatomical presentation of ML at diagnosis (MNH) by their reviewed histological subtypes (1996 -2006)

From: Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association

Reviewed histological diagnosis Anatomical Site [No. (%)] Reviewed cases with available clinical data Clinical data unrecorded Sub-totals Total reviewed ML
  Nodal Extranodal [No. (%)] [No. (%)] [No. (%)] [No. (%)]
DLBCL 35 (64.8) 7 (25.0) 42 15 57 (50.9)  
BL 2 (3.7) 15 (53.6) 17 6 23 (20.5)  
Other BCL* 17 (31.5) 6 (21.4) 23 9 32 (28.6)  
Total BCL 54 (83.1) 28 (80.0) 82 30 112 (83.6) 112 (83.6)
TCL 11 (16.9) 7 (20.0) 18 4   22 (13.7)
TOTAL NHL 65 (65.0) 35 (35.0) 100 34   134 (84.8)
HL 10 (66.7) 5 (33.3) 15 9   24 (15.2)
TOTAL REVIEWED ML [No. (%)] 75 (65.2) 40 (34.8) 115 (72.8) 43 (27.2)   158 (100.0)
  1. *BCL = B-cell lymphomas